Harsha Murthy, who was born in India of Indian parents, is a senior pharmaceuticals and finance executive who has served in leadership positions in the private sector, government and on nonprofit and for-profit boards. Mr. Murthy now serves as Secretary on the AAJC Board and was immediate past-Chairman of the Asian American Legal Defense and Education Fund (AALDEF). Mr. Murthy is currently the Managing Partner of Consummate Capital, LLC, a New York City-based fund that invests in pharmaceutical products.
Prior to Consummate Capital, Mr. Murthy was founding and managing partner of Konanda Pharma Partners, a New York City-based private equity fund that invested in mature branded pharmaceuticals. Prior to Konanda, Mr. Murthy was Executive Vice President and Corporate Head of Strategic Planning and Business Development for King Pharmaceuticals, where he led King's M&A, strategic licensing/alliance and divestiture activities. Before that, Mr. Murthy was an early team member at Eyetech Pharmaceuticals, which was one of the most successful biotech startups in history as it developed a treatment for age-related macular degeneration, the leading cause of blindness in the Western World. Mr. Murthy has also served as a managing director at GE Capital, where he focused on international equity/project finance investments in Asia, Africa, South America and the U.S. as well as working with kRoad Ventures, a venture capital fund focused in the energy sector. Mr. Murthy served as a Senior Counsel/Attorney-Fellow to the U.S. Securities and Exchange Commission in Washington, D.C.
Additionally, he has served on several public and non-profit boards, including the boards of Electrolux Corporation, the Duke University Libraries Advisory Board and as chairman for the Board of Battery Dance Company.
Mr. Murthy has been a frequent speaker before South Asian and civil rights organizations, industry and professional groups and at a number of colleges and universities. He is a graduate of Duke University and Stanford Law School.